Status:

UNKNOWN

Metformin Treatment on Cognitive Impairment of Schizophrenia Co-morbid Metabolic Syndrome

Lead Sponsor:

Central South University

Conditions:

Schizophrenia

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

In this study, the investigators will investigate the impact and the related mechanism of metformin treatment on cognitive impairment of schizophrenia with a high risk of metabolic syndrome. Patients ...

Detailed Description

In this study, the investigators will investigate the impact and the related mechanism of metformin treatment on cognitive impairment of schizophrenia with a high risk of metabolic syndrome. Patients ...

Eligibility Criteria

Inclusion

  • Meet the Diagnostic and Statistical Manual (DSM-5) diagnostic criteria for schizophrenia;
  • Duration of illness less than 5 years with current symptoms exacerbation;
  • Male and female aged 18 to 65 years;
  • PANSS total score \< 60 and CDSS-C total score \< 6;
  • Signed the study consent for participation;
  • Patients with higher risk factors for MetS, or patients who gained weight \> 10% of their pre-drug weight within the first year after antipsychotic medication.

Exclusion

  • Having a history of substance dependence or abuse or whose symptoms are caused by other diagnosable mental disorders;
  • Having a history of traumatic brain injury, seizures, or other known neurological or organic diseases of the central nervous system;
  • Taking antidepressants, stimulants, mood stabilizers or accepting electricity shock treatment;
  • Having current suicidal or homicidal thoughts or any safety concern by research staff that cannot be managed in an inpatient setting;
  • The routine blood tests showing abnormal renal, and liver function;
  • Pregnant or lactating women.

Key Trial Info

Start Date :

August 28 2017

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2023

Estimated Enrollment :

80 Patients enrolled

Trial Details

Trial ID

NCT03271866

Start Date

August 28 2017

End Date

December 31 2023

Last Update

April 11 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The Second Xiangya Hospital of Central South University

Changsha, Hunan, China, 410011